Edition:
United States

Benitec Biopharma Ltd (BNTC.OQ)

BNTC.OQ on NASDAQ Stock Exchange Capital Market

3.28USD
3:59pm EST
Change (% chg)

$-0.06 (-1.80%)
Prev Close
$3.34
Open
$3.33
Day's High
$3.33
Day's Low
$3.28
Volume
250
Avg. Vol
10,569
52-wk High
$5.48
52-wk Low
$1.85

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 192.73 34.59
P/E High - Last 5 Yrs. -- 285.47 45.93
P/E Low - Last 5 Yrs. -- 93.40 24.19
Beta -- 0.81 0.81
Price to Sales (TTM) -- 137.31 8.08
Price to Book (MRQ) -- 20.28 5.24
Price to Tangible Book (MRQ) -- 27.91 6.43
Price to Cash Flow (TTM) -- 126.48 25.98
% Owned Institutions -- 11.77 2.27

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.52
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.87 5.21
Payout Ratio(TTM) -- 8.18 43.34

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 65.12 9.76
Sales (TTM) vs TTM 1 Yr. Ago -- 62.55 7.61
Sales - 5 Yr. Growth Rate -- 33.48 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -- -97.40 18.78
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 46.98 11.55
Capital Spending - 5 Yr. Growth Rate -- 43.68 14.73

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.42
Current Ratio (MRQ) -- 6.12 3.39
LT Debt to Equity (MRQ) -- 16.26 12.18
Total Debt to Equity (MRQ) -- 18.35 15.60
Interest Coverage (TTM) -- -160.93 38.48

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.39 54.74
Gross Margin - 5 Yr. Avg. -- 55.21 52.50
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -233.45 14.67
Operating Margin (TTM) -- -490.18 4.40
Operating Margin - 5 Yr. Avg. -- -250.27 9.99
Pre-Tax Margin (TTM) -- -465.60 5.14
Pre-Tax Margin - 5 Yr. Avg. -- -256.86 10.24
Net Profit Margin (TTM) -- -447.98 1.86
Net Profit Margin - 5 Yr. Avg. -- -260.25 6.55
Effective Tax Rate (TTM) -- 0.27 21.87
Effective Tax Rate - 5 Yr. Avg. -- 17.76 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,887,942 823,803,020
Net Income/Employee (TTM) -- -537,326 96,327,335
Receivable Turnover (TTM) -- 14.02 5.44
Inventory Turnover (TTM) -- 2.38 3.52
Asset Turnover (TTM) -- 0.39 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.02 10.76
Return on Assets - 5 Yr. Avg. -- -0.09 12.05
Return on Investment (TTM) -- -0.67 13.67
Return on Investment - 5 Yr. Avg. -- 2.39 15.78
Return on Equity (TTM) -- -3.38 15.40
Return on Equity - 5 Yr. Avg. -- -1.61 17.04

Performance for Benitec Biopharma Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.82%
# of Holders: 8
Total Shares Held: 84,184
3 Mo. Net Change: 38,797
# New Positions: 4
# Closed Positions: 1
# Increased Positions: 5
# Reduced Positions: 1
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.